JP2016516058A5 - - Google Patents

Download PDF

Info

Publication number
JP2016516058A5
JP2016516058A5 JP2016503061A JP2016503061A JP2016516058A5 JP 2016516058 A5 JP2016516058 A5 JP 2016516058A5 JP 2016503061 A JP2016503061 A JP 2016503061A JP 2016503061 A JP2016503061 A JP 2016503061A JP 2016516058 A5 JP2016516058 A5 JP 2016516058A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
seleno
adenosyl
composition according
selenium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016503061A
Other languages
English (en)
Japanese (ja)
Other versions
JP6313418B2 (ja
JP2016516058A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/029328 external-priority patent/WO2014144776A1/en
Publication of JP2016516058A publication Critical patent/JP2016516058A/ja
Publication of JP2016516058A5 publication Critical patent/JP2016516058A5/ja
Application granted granted Critical
Publication of JP6313418B2 publication Critical patent/JP6313418B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016503061A 2013-03-15 2014-03-14 セレンを含む組成物、並びにミトコンドリア機能不全と関連する疾患または状態の処置および予防のためのその使用 Active JP6313418B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361788133P 2013-03-15 2013-03-15
US61/788,133 2013-03-15
PCT/US2014/029328 WO2014144776A1 (en) 2013-03-15 2014-03-14 Compositions comprising selenium and use of same for the treatment and prevention of disease or conditions associated with mitochondrial dysfunction

Publications (3)

Publication Number Publication Date
JP2016516058A JP2016516058A (ja) 2016-06-02
JP2016516058A5 true JP2016516058A5 (https=) 2017-04-06
JP6313418B2 JP6313418B2 (ja) 2018-04-18

Family

ID=51537786

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016503061A Active JP6313418B2 (ja) 2013-03-15 2014-03-14 セレンを含む組成物、並びにミトコンドリア機能不全と関連する疾患または状態の処置および予防のためのその使用

Country Status (15)

Country Link
US (1) US9833486B2 (https=)
EP (1) EP2968404A4 (https=)
JP (1) JP6313418B2 (https=)
KR (1) KR102245702B1 (https=)
CN (3) CN114533753A (https=)
AU (1) AU2014228785B2 (https=)
BR (1) BR112015022514A2 (https=)
CA (1) CA2903845C (https=)
CL (1) CL2015002677A1 (https=)
HK (1) HK1216506A1 (https=)
MX (1) MX359626B (https=)
RU (1) RU2663127C2 (https=)
SG (2) SG10202101918RA (https=)
WO (1) WO2014144776A1 (https=)
ZA (1) ZA201506759B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX384232B (es) 2013-03-14 2025-03-14 Jerome J Schentag Vesiculas colestosomicas para incorporacion de moleculas en quilomicrones.
RU2665135C2 (ru) * 2014-03-14 2018-08-28 Олтек, Инк. Композиции селеноорганических соединений и способы их применения
WO2016160594A1 (en) 2015-03-27 2016-10-06 The Research Foundation For The State University Of New York Methods and materials for reducing amyloid beta levels within a mammal
WO2017048252A1 (en) * 2015-09-15 2017-03-23 Alltech, Inc. Compositions of selenoorganic compounds and methods of use thereof
WO2017160678A1 (en) * 2016-03-14 2017-09-21 Mitogenetics, Llc Materials and methods for treating hypoxic conditions
AU2018269403B2 (en) 2017-05-19 2025-03-27 Alltech, Inc. Pharmaceutical agents, compositions, and methods relating thereto
JP7250810B2 (ja) * 2018-04-25 2023-04-03 オンコクロス カンパニー,リミテッド 筋肉疾患の予防及び治療用組成物
CN108283711A (zh) * 2018-05-06 2018-07-17 冷立娟 一种治疗酒精性心肌病的中药冲剂及其制备方法
CN109820933A (zh) * 2019-02-27 2019-05-31 北京曲佳科技有限公司 减肥片及其制备方法
CN111493325A (zh) * 2020-05-07 2020-08-07 恩施德源健康科技发展有限公司 植物硒肽在制备改善肥胖及代谢综合征组合物中的应用
US20230129707A1 (en) * 2020-06-29 2023-04-27 Bristol-Myers Squibb Company Automated system and method for analyzing samples from a bioreactor
CN112129864B (zh) * 2020-09-24 2022-04-01 江南大学 一种富硒植物干粉中硒形态测定的方法
KR102328808B1 (ko) * 2020-12-02 2021-11-22 동의대학교 산학협력단 맥주효모를 이용한 근감소증 예방 및 개선용 조성물
CN114053298A (zh) * 2021-11-19 2022-02-18 华中农业大学 一种用于抑制心肌肥大的药物及模型的构建方法
CN114235989A (zh) * 2021-11-27 2022-03-25 山东省烟台市农业科学研究院 一种测定福美甲胂含量的高效液相色谱法
CN114031650B (zh) * 2021-11-29 2023-05-02 上海交通大学 壳寡糖硒配位化合物及其制备方法和应用
CN114924001B (zh) * 2022-05-12 2024-11-19 中国计量科学研究院 一种基于独立校准的含磷或含硒化合物标准溶液定值方法
CN114931569B (zh) * 2022-06-22 2023-05-16 中国农业科学院油料作物研究所 甲基硒代半胱氨酸在制备提高雄性生殖能力的产品中的应用
CN116333302B (zh) * 2023-03-31 2024-09-10 中南大学 一种稳定持久抗氧化纳米点及其在二型糖尿病中的应用
CN116421618B (zh) * 2023-06-15 2023-09-29 暨南大学 Se@NADH的制备方法及其在脊髓损伤治疗中的应用
CN120531844A (zh) * 2025-07-02 2025-08-26 内蒙古肽元生物科技有限公司 生物活性肽在增强哺乳动物卵母细胞成熟及胚胎发育潜能中的应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5896024A (ja) * 1981-10-16 1983-06-07 リチヤ−ド・エフ・ストツケル 白金毒解毒剤
US5221545A (en) 1992-03-09 1993-06-22 Abbott Laboratories Method of providing selenium in a nutritional product
US6197295B1 (en) 1996-09-25 2001-03-06 Viva America Marketing Corporation Dietary supplementation with, and methods for administration of yeast-derived selenium product
US6911550B2 (en) 2003-02-21 2005-06-28 Zinpro Corporation Derivatives of seleno-amino acids with improved bioavailability and method for their preparation
OA13177A (en) * 2003-06-04 2006-12-13 Willem Jacob Serfontein Nutritional compositions and use thereof.
PL214402B1 (pl) * 2003-08-11 2013-07-31 Tomasz Byrski Zastosowanie selenu albo jego zwiazku do otrzymywania srodka do obnizania odziedziczonego ryzyka zachorowania na raka piersi lub jajnika
US20050069594A1 (en) 2003-08-11 2005-03-31 Jan Lubinski Pharmaceutical compositions and methods for the prevention of breast and ovarian cancer
WO2005023274A1 (en) * 2003-09-05 2005-03-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Treatment and prevention of inflammatory disease and mitochondrial dysfunction with high dose selenium
US8871715B2 (en) * 2005-10-14 2014-10-28 Alltech, Inc. Use of selenium compounds, especially selenium yeasts for altering cognitive function
TWI319708B (en) * 2005-10-14 2010-01-21 Methods and compositions for altering cell fuction
US20100247679A1 (en) * 2006-04-24 2010-09-30 Alltech, Inc. Methods and compositions for altering cell function
US8846111B2 (en) * 2007-05-18 2014-09-30 Alltech, Inc. Compositions and methods for establishing and/or maintaining pregnancy
WO2009018492A2 (en) * 2007-07-31 2009-02-05 The Board Of Regents Of The University Of Texas System Micro-rnas that control myosin expression and myofiber identity
WO2009032057A2 (en) * 2007-08-29 2009-03-12 Adam Lubin Method for the selective therapy of disease
ES2378595T3 (es) * 2007-10-16 2012-04-16 Actigenomics S.A. Composición destinada a la regulación del metabolismo de los lípidos
CN101579355B (zh) * 2009-05-27 2010-12-08 徐建兴 一种维护线粒体功能的营养组合物及其应用
EP3095458B1 (en) * 2009-10-22 2018-07-25 Propanc Pty Ltd Pharmaceutical composition for treating cancer comprising trypsinogen and chymotrypsinogen
US8575320B2 (en) 2010-03-18 2013-11-05 Alltech, Inc. Compositions and methods for separating, characterizing and administering soluble selenoglycoproteins
WO2011132799A1 (en) * 2010-04-22 2011-10-27 Kyoto University Method for inducing differentiation of pluripotent stem cells into skeletal muscle or skeletal muscle progenitor cells
KR20120048205A (ko) * 2010-11-05 2012-05-15 한국식품연구원 메틸셀레노시스테인을 유효성분으로 함유하는 비만 및 지질 관련 대사성 질환의 예방 및 치료용 조성물
EP2705844B1 (en) 2011-04-13 2019-05-22 Ajinomoto Co., Inc. Nutritional composition

Similar Documents

Publication Publication Date Title
JP2016516058A5 (https=)
CY1124878T1 (el) Διασπειρομενη στο στομα δοσολογικη μοναδα η οποια περιεχει ενα συστατικο οιστετρολης
JP2012031147A5 (https=)
JP2012031131A5 (https=)
JP2015078230A5 (https=)
IL295418B1 (en) Beta-d-2'-deoxy-2' alpha-fluoro-2'-bata-c-modified-2-different-n6-purine modified nucleotides for the treatment of hepatitis c virus
JP2014111603A5 (https=)
CL2014002324A1 (es) Metodo para lentificar el avance, demorar o tratar la prediabetes en un paciente con sobrepeso u obeso que comprende la administracion de empagliflozina y uno o varios fármacos antiobesidad y composición farmacéutica que comprende a dichos farmacos.
PL3793534T3 (pl) Tabletka doustna do dostarczania składników czynnych do przewodu żołądkowo-jelitowego
JP2016515611A5 (https=)
JP2014218522A5 (https=)
BR112014014795A2 (pt) sistema de pélete de multiunidade de liberação imediata
IL280083A (en) A pharmaceutical dosage form that can be administered orally and with a modified release
RU2016131454A (ru) Применения витамина d и его композиций для антибиоза
JP2014062109A5 (https=)
JP2016513680A5 (https=)
HRP20220701T1 (hr) Spojeni benzazepini za liječenje touretteova sindroma
HRP20161796T1 (hr) Farmaceutski pripravak za primjenu u tretmanu ili prevenciji deficijencije vitamina i minerala kod pacijenata podvrgnutih operaciji želučane premosnice
HK1218862A1 (zh) 包含异烟肼颗粒和利福喷汀颗粒的呈包衣片剂形式的抗结核病的稳定的药物组合物及其制备方法
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
EP3065737A4 (en) Oral pharmaceutical form for preventing vascular diseases, tablet as pharmaceutical form and gelatin capsule as pharmaceutical form
RU2016105763A (ru) Препараты метаксалона
HRP20171305T1 (hr) Upotreba odiparcila u liječenju mukopolisaharidoze
RU2019122120A (ru) Пероральный препарат ибупрофена
HUE037827T2 (hu) Nátrium-ibuprofen tabletták és eljárások nátrium-ibuprofent tartalmazó gyógyszerészeti készítmények elõállítására